Mid-Day Market Update: Gold Down 1%; Immix Biopharma Shares Spike Higher
Midway through trading Monday, the Dow traded up 0.18% to 36,402.21 while the NASDAQ rose 0.75% to 15,762.21. The S&P also rose, gaining 0.23% to 4,776.99.
35 Stocks Moving In Monday’s Mid-Day Session
Gainers
Immix Biopharma, Inc. (NASDAQ: IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-110 for rhabdomyosarcoma, a form of pediatric cancer.
Mid-Morning Market Update: Markets Edge Higher; Tesla Q4 Deliveries Top Estimates
Following the market opening Monday, the Dow traded up 0.11% to 36,378.68 while the NASDAQ rose 0.18% to 15,673.75. The S&P also rose, gaining 0.11% to 4,771.56.
10 Information Technology Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Jim Cramer Shares His Thoughts On New Relic, DraftKings And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said New Relic, Inc. (NYSE: NEWR) recorded one of the most "unbelievable quarters."
Jim Cramer Prefers Sea Over Coupang, Considers iStar Inexpensive
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Himax Technologies, Inc (NASDAQ: HIMX) is a "so-so integrated circuits" firm. He recommends buying Marvell Technology, Inc.